Brief: Endo Acquires Six Development-Stage, Ready-To-Use Injectable Product Candidates From Nevakar
02/05/2022 13:24
May 2 (Reuters) - Endo International PLC ENDP.O :
* ENDO ACQUIRES SIX DEVELOPMENT-STAGE, READY-TO-USE
INJECTABLE
PRODUCT CANDIDATES FROM NEVAKAR
* ENDO INTERNATIONAL PLC - ACQUISITION IS SEPARATE FROM CO'S
PREVIOUSLY ANNOUNCED EXCLUSIVE LICENSING AGREEMENT WITH NEVAKAR
* ENDO INTERNATIONAL PLC - UNDER TERMS OF AGREEMENT, EVL
PURCHASED
SIX PRODUCT CANDIDATES FROM NEVAKAR INJECTABLES FOR A ONE-TIME
PAYMENT OF $35 MILLION
Source text for Eikon: ID:nCNWxdqG2a
Further company coverage: ENDP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Endo International
See all newsBrief: Endo International PLC Files For Offering Of Up To 31.1 Million Common Shares By The Selling Stockholders - SEC Filing
Brief: Par Pharmaceutical Issues Voluntary Nationwide Recall Of Seven Lots Of Treprostinil Injection
Brief: Endo International Says Wholly-Owned Subsidiary Endo Finance Priced Its $1.5 Bln Senior Secured Seven-Year Term Loan
Brief: Endo, Inc. Announces Pricing Of $1 Bln Of Senior Secured Notes
Brief: Endo Announces Proposed Private Offering Of Senior Secured Notes